- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Invitrocue
Invitrocue is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.
View Invitrocue on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
1
Countries
1
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Antibodies
- Antibody Humanization Increase an antibody's similarity to a variant produced naturally in humans.
Biomarkers
- Human Primary Cell Isolation Isolate primary cells from various human tissues.
Cell Culture and Characterization
- 3D Cell Culture Use a scaffold-based or scaffold-free format to grow three dimensional cell and tissue structures.
- Adherent Cell Culture Grow monolayers of anchorage-dependent cells.
- Cell Culture Culture primary or immortalized cell lines.
- Histology Examine by microscopy the anatomy of cells and tissues of clinical patients and animal models.
Disease Models
- Acute Lung Injury Models Measure therapeutic endpoints in animal models of acute lung injury.
- Arthritis Models Measure therapeutic endpoints in animal models of arthritis.
- Cardiovascular Models Test the therapeutic efficacy of drug candidates in cardiovacular disease models.
- Hepatitis B Virus Models Measure therapeutic endpoints in animal models of Hepatitis B virus infection.
- Hepatitis C Virus Models Measure therapeutic endpoints in animal models of Hepatitis C virus infection.
- Infectious Disease Models Test therapeutic efficacy of drug candidate in infectious disease model.
Show all 14 in Disease Models
- Inflammation Models Measure therapeutic endpoints in animal models for inflammation.
- Inflammatory Bowel Disease Models Measure IBD symptom severity, cytokine levels and body weight, and evaluate IHC and Ariol images.
- LPS Lung Inflammation Models Measure therapeutic endpoints in animal models of inflammation.
- Pulmonary Fibrosis Models Measure therapeutic endpoints in animal models of pulmonary fibrosis.
- Respiratory Models Test therapeutic efficacy of drug candidate in respiratory disease model.
- Systemic Lupus Erythematosus Models Measure therapeutic endpoints in animal models of immune disorders such as SLE and lupus.
- Viral Infection Models Measure therapeutic endpoints in animal models of viral infection.
- Xenografts Evaluate drug candidate in tissue graft or organ transplant model.
Show all 44 services
Human Biological Samples
- Custom PDX models For requesting Custom PDX models
- Human Organoids Test immuno-oncology drugs and therapies on fresh, unpropagated 3D tumor organoids to evaluate efficacy and understand drug mechanism of action. Understand the intact tumor immune microenvironment, cytotoxic efficacy...
In Vitro ADME
- Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
- Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
In Vitro Assays
- 3Screen™ 3D In Vitro Services 3Screen™ Platform enables complete 3D cell culture characterization.
- Antivirals Measure anti-viral activity in biochemical and cell assays.
In Vitro Pharmacology
- Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Assays Use biochemical, cell based or in vivo assays to measure CTLA-4 receptor activity.
- HuGEMM - Immuno-Oncology Model Evaluate human-specific therapeutics for checkpoint inhibitors, including anti-human PD-1, anti-human PDL-1, and anti-human CTLA-4 antibodies.
- Immuno-oncology Assays Use biochemical, cell based or in vivo assays to measure the activity of immuno-therapy targets.
- In Vitro Oncology Models Use cell-based and biochemical models of cancer.
- Programmed Cell Death-1 (PD-1) Assays Use biochemical, cell based or in vivo assays to measure PD-1 receptor activity.
- Programmed Death-Ligand 2 (PD-L2) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of PD-L2 ligand.
Show all 7 in In Vitro Pharmacology
- Vascular Endothelial Growth Factor (VEGF) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of VEGF ligand.
In Vitro Toxicology
- Cytotoxicity Test for effects on cell viability and proliferation
- Hepatocyte Toxicity Assess the cytotoxic effects of pre-clinical compounds on hepatocytes purified from patients and animal models.
Model Development
- PBMC Humanized Mice Study and evaluate compounds for infectious diseases and graft rejection.
Oncology Models
- Oncology Derived PDX Patient derived xenografts derived from various oncological samples. This includes, but is not limited to, samples from Lymphoma, Melanoma, and Leukemia.
- Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.
- Oncology Xenografts Xenografts derived from oncological samples.
- Ovarian Cancer Mouse Measure therapeutic endpoints in animal models of ovarian cancer.
- Xenograft Models Measure therapeutic endpoints in cancer models using tumor cells transplanted from a donor of a different species.
Other Specialty Toxicology
- Viral Testing Characterize viral products for functional activity and possible contamination.
Safety Pharmacology
- Immunotoxicity Measure effects of drugs on immune function, allergic hypersensitization and autoimmune toxicity.
- Respiratory Toxicology Assess difficulty breathing, altered respiration, blood gas changes and blood pH issues due to adverse reactions.
- Website
- www.invitrocue.com
Where it operates
Sites by country, with the cities in each.
-
Singapore 1 site
Work with Invitrocue on Scientist.com
For prices, more details, or to contact Invitrocue, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.